Inventor · disambiguated record
Peter A. Mccarthy
Also filed as: MCCARTHY PETER A · MCCARTHY PETER ANDREW
11 granted patents·258 citations·filing 1987–1995
90Inventor score
Files withPFIZER11
Top patents by PatentIndex Score
11 records- 0196US5656634AN-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)PFIZER·Filed 1994·Granted Aug 12, 1997·97 cites·7 claims
- 0295US5362878AIntermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)PFIZER·Filed 1992·Granted Nov 8, 1994·73 cites·5 claims
- 0379US5629295ASteroidal glycosides for treating hypercholesterolemiaPFIZER·Filed 1993·Granted May 13, 1997·27 cites·36 claims
- 0474US5703052ASterodial glycosides for treating hypercholesterolemiaPFIZER·Filed 1995·Granted Dec 30, 1997·26 cites·14 claims
- 0564US6150336ASteroidal glycosidesPFIZER·Filed 1995·Granted Nov 21, 2000·19 cites·7 claims
- 0653US5332857A3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agentsPFIZER·Filed 1992·Granted Jul 26, 1994·9 cites·11 claims
- 0749US5151545A3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agentsPFIZER·Filed 1987·Granted Sep 29, 1992·4 cites·6 claims
- 0840US5026715A2-guanidino-4-arylthiazoles for treatment of peptic ulcersPFIZER·Filed 1989·Granted Jun 25, 1991·2 cites·25 claims
- 0934US5169976AN-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agentsPFIZER·Filed 1987·Granted Dec 8, 1992·1 cites·11 claims
- 1032US4996345ADifluoroketones from difluoroacylsilanesPFIZER·Filed 1989·Granted Feb 26, 1991·0 cites·15 claims
- 1130US5057626ADifluoroketones from difluoroacylsilanesPFIZER·Filed 1990·Granted Oct 15, 1991·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Peter A. Mccarthy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →